Chemokine concentrations and mast cell chemotactic activity in BAL fluid in patients with eosinophilic bronchitis and asthma, and in normal control subjects.

BACKGROUND Asthma and eosinophilic bronchitis share many immunopathologic features including increased numbers of eosinophils and mast cells in the superficial airway. The mast cell chemotactic activity of airway secretions has not been assessed in patients with eosinophilic bronchitis. OBJECTIVES To investigate the concentration of chemokines in bronchial wash samples and BAL fluid, and the mast cell chemotactic activity in BAL fluid from subjects with asthma and eosinophilic bronchitis, and from healthy control subjects. METHODS We measured the concentrations of CCL11, CXCL8, and CXCL10 in bronchial wash samples and BAL fluid from 14 subjects with eosinophilic bronchitis, 14 subjects with asthma, and 15 healthy control subjects. Mast cell chemotaxis to BAL fluid from these subjects was examined using the human mast cell line HMC-1. RESULTS The bronchial wash sample and BAL fluid concentrations of CXCL10 and CXCL8 was increased in subjects with eosinophilic bronchitis compared to those in subjects with asthma and healthy control subjects (p < 0.05). The CCL11 concentration was below the limit of detection in most subjects. BAL fluid from subjects with eosinophilic bronchitis was chemotactic for mast cells (1.4-fold migration compared to a control, 95% confidence interval, 1.1 to 1.9; p = 0.04) and was inhibited by blocking CXCR1 (45% inhibition; p = 0.002), CXCR3 (38% inhibition; p = 0.034), or both (65% inhibition; p = 0.01). BAL fluid from the subjects with asthma and healthy control subjects was not chemotactic for mast cells. Mast cell migration to BAL fluid was correlated with the concentration of CXCL8 (r = 0.42; p = 0.031) and CXCL10 (r = 0.52; p = 0.007). CONCLUSION In subjects with eosinophilic bronchitis, CXCL8 and CXCL10 concentrations were elevated in airway secretions. These chemokines may play a key role in mast cell recruitment to the superficial airway in this condition.

[1]  Choon-Sik Park,et al.  Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma. , 2005, Chest.

[2]  C. Brightling,et al.  The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. , 2005, American journal of respiratory and critical care medicine.

[3]  A. Morgan,et al.  Differential expression of CCR3 and CXCR3 by human lung and bone marrow‐derived mast cells: implications for tissue mast cell migration , 2005, Journal of leukocyte biology.

[4]  I. Pavord,et al.  Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. , 2004, The Journal of allergy and clinical immunology.

[5]  S. Durham,et al.  CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge , 2004, European Respiratory Journal.

[6]  W. Busse,et al.  Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. , 2004, American journal of respiratory and critical care medicine.

[7]  R. Djukanović,et al.  Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. , 2004, American journal of respiratory and critical care medicine.

[8]  D. Liggitt,et al.  Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells , 2004, Nature Immunology.

[9]  H. Sarau,et al.  The FASEB Journal express article 10.1096/fj.03-0170fje. Published online Novermber 3, 2003. Regulation of TNF-α and IFN-γ induced CXCL10 , 2022 .

[10]  I. Pavord,et al.  Induced sputum inflammatory mediator concentrations in chronic cough. , 2004, American journal of respiratory and critical care medicine.

[11]  P. Gibson.  Cough is an airway itch? , 2004, American journal of respiratory and critical care medicine.

[12]  M. Liu,et al.  Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. , 2003, The Journal of allergy and clinical immunology.

[13]  I. Pavord,et al.  Comparison of airway immunopathology of eosinophilic bronchitis and asthma , 2003, Thorax.

[14]  I. Pavord,et al.  New insights into the role of the mast cell in asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  I. Pavord,et al.  TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. , 2002, The Journal of allergy and clinical immunology.

[16]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[17]  A. James,et al.  Distribution and degranulation of airway mast cells in normal and asthmatic subjects , 2002, European Respiratory Journal.

[18]  S. Holgate,et al.  Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? , 2001, American journal of respiratory and critical care medicine.

[19]  P. Bradding,et al.  Voltage‐dependent and calcium‐activated ion channels in the human mast cell line HMC‐1 , 2001, Journal of leukocyte biology.

[20]  E. Israel,et al.  Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. , 2001, American journal of respiratory and critical care medicine.

[21]  J. Lafitte,et al.  Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. , 2001, The Journal of allergy and clinical immunology.

[22]  G. Nilsson,et al.  Demonstration of mast cell chemotactic activity in bronchoalveolar lavage fluid collected from asthmatic patients before and during pollen season. , 2000, The Journal of allergy and clinical immunology.

[23]  I. Pavord,et al.  Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. , 2000, American journal of respiratory and critical care medicine.

[24]  F. Annunziato,et al.  Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. , 1999, The American journal of pathology.

[25]  A J Wardlaw,et al.  Eosinophilic bronchitis is an important cause of chronic cough. , 1999, American journal of respiratory and critical care medicine.

[26]  Q. Hamid,et al.  The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. , 1999, Journal of immunology.

[27]  W. Sewell,et al.  Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. , 1998, Journal of Allergy and Clinical Immunology.

[28]  Q. Hamid,et al.  Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. , 1997, Journal of immunology.

[29]  P. Gibson,et al.  A systematic evaluation of mechanisms in chronic cough. , 1997, American journal of respiratory and critical care medicine.

[30]  I. Pavord,et al.  The use of induced sputum to investigate airway inflammation. , 1997, Thorax.

[31]  P. Howarth,et al.  Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. , 1994, American journal of respiratory cell and molecular biology.

[32]  J. Denburg,et al.  Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. , 1993, The American review of respiratory disease.

[33]  S. Mattoli,et al.  Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. , 1992, The Journal of allergy and clinical immunology.

[34]  J. Denburg,et al.  CHRONIC COUGH: EOSINOPHILIC BRONCHITIS WITHOUT ASTHMA , 1989, The Lancet.

[35]  J. Gerrard,et al.  Letter: Sex-linked mental retardation. , 1974, Lancet.